Background alzheimers Shape Background alzheimers Shape Background alzheimers Shape
Grants > Regulation of Amyloidogenic Secretases During Apoptosis Updated On: Jan. 19, 2025
Alzheimer's Disease Research Grant

Regulation of Amyloidogenic Secretases During Apoptosis

a headshot of Dr. Tanzi

Principal Investigator

Rudolph Tanzi, PhD

Massachusetts General Hospital

Boston, MA, USA

About the Research Project

Program

Alzheimer's Disease Research

Award Type

Standard

Award Amount

$300,000

Active Dates

April 01, 2005 - March 31, 2007

Grant ID

A2005015

Summary

Evidence is accumulating that stroke significantly increases the risk of AD representing either a precipitating or a triggering event. Extensive studies have shown that stroke or head trauma results in neuronal cell death by the activation of a cell death program termed apoptosis. Apoptosis is characterized by the activation of a family of protease called caspases. The pharmacological inhibition of caspases has been shown to reduce cell death. Dr. Tanzi’s findings indicate that treatment of stroke and head trauma with caspase inhibitors might be useful not only to prevent neuronal cell death as a consequence of the acute events, but also to prevent the increase in Aβ production that contributes to AD pathogenesis. Dr. Tanzi’s proposed experiments should not only increase our understanding of the regulation of the amyloidogenic secretases, but suggest novel therapeutic strategies for treating and preventing AD.